GlassScriptPhysician profile
Braden J Foster
NPI 1124313598
$4,062.71
in general payments reported to CMS, 2019-2025
44 companies · $1,454 in 2025
The $1,454 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $187 · 2021: $390 · 2022: $290 · 2023: $298 · 2024: $1,170 · 2025: $1,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,922.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $609.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $558.42 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $530.27 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $399.25 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $246.92 | 2021-2025 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals LP | $229.01 | 2020-2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $121.96 | 2019-2025 | Repatha, Otezla, Repatha |
| Sumitomo Pharma America, INC. | $87.46 | 2023-2025 | Gemtesa |
| Ironshore Pharmaceuticals INC. | $82.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.63 | 2020-2025 | Ofev, Jardiance |
| Sanofi Pasteur INC. | $79.12 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $76.66 | 2019-2021 | |
| Medtronic, INC. | $72.13 | 2023-2025 | Intellis Adaptivestim |
| Biohaven Pharmaceutical Holding Company LTD. | $69.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $59.41 | 2020-2024 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Braden Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.